Agenus Inc SEC filings AGEN
Agenus Inc has 1,003 filings in SEC EDGAR's recent list, going back to Apr 29, 2014. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 14, 2026 | — |
| EFFECT | Filing | Jul 27, 2026 | — |
| DEFR14A | Filing | Jun 6, 2025 | — |
| EFFECT | Filing | May 30, 2025 | — |
| CORRESP | Letter to the SEC | May 28, 2025 | — |
| UPLOAD | Letter from the SEC | May 15, 2025 | — |
| DEFR14A | Filing | May 5, 2025 | — |
| EFFECT | Filing | Mar 18, 2024 | — |
| POSASR | Filing | Mar 14, 2024 | — |
| EFFECT | Filing | Nov 22, 2019 | — |
| CORRESP | Letter to the SEC | Nov 19, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2019 | — |
| CORRESP | Letter to the SEC | Nov 8, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2019 | — |
| CORRESP | Letter to the SEC | Oct 7, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2019 | — |
| CT ORDER | Filing | Aug 2, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| CT ORDER | Filing | Apr 11, 2019 | — |
| CT ORDER | Filing | Mar 28, 2019 | — |
| D | Filing | Feb 1, 2019 | — |
| RW | Filing | Dec 21, 2018 | — |
| EFFECT | Filing | Dec 10, 2018 | — |
| CORRESP | Letter to the SEC | Dec 7, 2018 | — |
| CT ORDER | Filing | Dec 4, 2018 | — |
| D | Filing | Oct 25, 2018 | — |
| EFFECT | Filing | Jan 19, 2018 | — |
| CORRESP | Letter to the SEC | Jan 17, 2018 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2018 | — |
| CORRESP | Letter to the SEC | Dec 18, 2017 | — |
| CORRESP | Letter to the SEC | Dec 14, 2017 | — |
| CORRESP | Letter to the SEC | Dec 12, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2017 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2017 | — |
| EFFECT | Filing | Oct 30, 2017 | — |
| CORRESP | Letter to the SEC | Oct 26, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2017 | — |
| CT ORDER | Filing | Sep 12, 2017 | — |
| CT ORDER | Filing | Jun 20, 2017 | — |
| CT ORDER | Filing | Jun 6, 2017 | — |
| EFFECT | Filing | Mar 31, 2017 | — |
| CORRESP | Letter to the SEC | Mar 30, 2017 | — |
| CT ORDER | Filing | Mar 2, 2017 | — |
| D | Filing | Mar 1, 2017 | — |
| CORRESP | Letter to the SEC | Feb 23, 2017 | — |
| CT ORDER | Filing | Feb 23, 2017 | — |
| CORRESP | Letter to the SEC | Feb 22, 2017 | — |
| CORRESP | Letter to the SEC | Jan 26, 2017 | — |
| UPLOAD | Letter from the SEC | Jan 25, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2016 | — |
| EFFECT | Filing | May 17, 2016 | — |
| CORRESP | Letter to the SEC | May 16, 2016 | — |
| EFFECT | Filing | Apr 28, 2016 | — |
| EFFECT | Filing | Apr 28, 2016 | — |
| CORRESP | Letter to the SEC | Apr 27, 2016 | — |
| CORRESP | Letter to the SEC | Apr 27, 2016 | — |
| CT ORDER | Filing | Apr 26, 2016 | — |
| CORRESP | Letter to the SEC | Apr 26, 2016 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2016 | — |
| CT ORDER | Filing | Mar 29, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 11, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 8, 2016 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2016 | — |
| D | Filing | Jan 8, 2016 | — |
| EFFECT | Filing | Jan 5, 2016 | — |
| D | Filing | Jan 4, 2016 | — |
| CORRESP | Letter to the SEC | Jan 4, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2015 | — |
| CT ORDER | Filing | Nov 6, 2015 | — |
| D | Filing | Sep 23, 2015 | — |
| EFFECT | Filing | Sep 10, 2015 | — |
| CORRESP | Letter to the SEC | Sep 9, 2015 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2015 | — |
| EFFECT | Filing | Jun 8, 2015 | — |
| CORRESP | Letter to the SEC | Jun 5, 2015 | — |
| CT ORDER | Filing | Jun 4, 2015 | — |
| CT ORDER | Filing | May 29, 2015 | — |
| UPLOAD | Letter from the SEC | May 6, 2015 | — |
| CT ORDER | Filing | Apr 29, 2015 | — |
| D | Filing | Mar 5, 2015 | — |
| D | Filing | Mar 5, 2015 | — |
| EFFECT | Filing | Oct 23, 2014 | — |
| EFFECT | Filing | Jun 18, 2014 | — |
| CORRESP | Letter to the SEC | Jun 17, 2014 | — |
| CT ORDER | Filing | Jun 16, 2014 | — |
| UPLOAD | Letter from the SEC | May 21, 2014 | — |
Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AGEN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1098972
- Former names
- ANTIGENICS INC /DE/ (until Jan 5, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.